Novel autoantibodies and clinical phenotypes in adult and juvenile myositis (Q35092898)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Novel autoantibodies and clinical phenotypes in adult and juvenile myositis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5 references

13 March 2019

25 April 2019

18 June 2019

27 November 2019

13 December 2019

Novel autoantibodies and clinical phenotypes in adult and juvenile myositis (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5 references

13 March 2019

25 April 2019

18 June 2019

27 November 2019

13 December 2019

1 reference

27 November 2019

1 reference

13 December 2019

1 reference

based on heuristic

inferred from title

author name string

Zoe E Betteridge

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Harsha Gunawardena

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Neil J McHugh

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

18 March 2011

6 references

Europe PubMed Central

PubMed publication ID

6 August 2017

13 March 2019

25 April 2019

18 June 2019

27 November 2019

13 December 2019

Arthritis Research and Therapy

6 references

Europe PubMed Central

PubMed publication ID

6 August 2017

13 March 2019

25 April 2019

18 June 2019

27 November 2019

13 December 2019

13

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

209

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Malignancy and myositis: novel autoantibodies and new insights.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

UV radiation regulates Mi-2 through protein translation and stability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Myopathy with antibodies to the signal recognition particle: clinical and pathological features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding, and coiled-coil domains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Autoantibody profiles in the sera of European patients with myositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Clinical significance of specific autoantibodies in juvenile dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Human autoantibodies reactive with the signal-recognition particle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

9 July 2018

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

1 reference

https://api.crossref.org/works/10.1186%2FAR3275

21 January 2018

Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-se

1 reference

https://api.crossref.org/works/10.1186%2FAR3275

21 January 2018

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

1 reference

https://api.crossref.org/works/10.1186%2FAR3275

21 January 2018

Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.

1 reference

https://api.crossref.org/works/10.1186%2FAR3275

21 January 2018

Autoantibody to signal recognition particle in African American girls with juvenile polymyositis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3132021

27 September 2018

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

1 reference

https://api.crossref.org/works/10.1186%2FAR3275

21 January 2018

Classification criteria for polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association between Mi-2 antibodies and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to signal recognition particle in polymyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21457520

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35092898&oldid=2197238071"